Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

248 results
Display

Can proton pump inhibitors cause intestinal inflammation in children?

Kang B

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Is hypomagnesemia associated with using proton pump inhibitors?

Yi JH, Han SW

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Do Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Really Have No Effect on the Gastric Emptying Rate?

Tomita T, Miwa H

  • KMID: 2325851
  • J Neurogastroenterol Motil.
  • 2011 Oct;17(4):434-434.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Can Proton Pump Inhibitors Increase Incidence of Nonsteroidal Anti-inflammatory Druginduced Small Bowel Injury?

Jeon SR

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Can Nocturnal Acid-breakthrough Be Reduced by Long-acting Proton Pump Inhibitors?

Jeon HK, Kim GH

  • KMID: 2433514
  • J Neurogastroenterol Motil.
  • 2017 Apr;23(2):145-148.
  • doi: 10.5056/jnm17037
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Proton Pump Inhibitors Reduce the Size and Acidity of the Gastric Acid Pocket

Jo Y

  • KMID: 2381241
  • J Neurogastroenterol Motil.
  • 2015 Jan;21(1):133-134.
  • doi: 10.5056/jnm14152
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effect of Proton Pump Inhibitors on Nutrition, Metabolism, Infection and Small Intestinal Bacterial Overgrowth: Safe Perspective

Kim JH

  • KMID: 2263935
  • Korean J Med.
  • 2011 Jul;81(1):11-16.
Proton pump inhibitors (PPIs) have been widely used to treat patients with acid-related disorders because they are perceived to be safe and effective. However, they have the potential for side...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Do Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Really Have No Effect on the Gastric Emptying Rate?: Author's Reply

Nonaka T, Inamori M

  • KMID: 2325852
  • J Neurogastroenterol Motil.
  • 2011 Oct;17(4):435-435.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Proton Pump Inhibitor-Responsive Esophageal Eosinophilia: Controversies and Its Clinical Implications

Shin CM, Lee DH

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Proton Pump Inhibitors with Clopidogrel: Is There Benefit or Harm?

Jeon SW

  • KMID: 2258973
  • Korean J Med.
  • 2011 Apr;80(4):405-407.
The treatment of acute coronary syndromes involves a combination of antiplatelet therapies. Proton pump inhibitors (PPIs) are often recommended for prophylaxis of gastrointestinal bleeding. Recent studies have shown that the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of Risk factors and Clinical Responses to Proton Pump Inhibitors in Patients with Erosive esophagitis and Non-erosive reflux disease (Aliment Pharmacol Ther 2009;30:154-164)

Kim N

  • KMID: 2307414
  • Korean J Neurogastroenterol Motil.
  • 2009 Dec;15(2):145-146.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pathophysiological Studies Are Mandatory to Understand the Benefit of Proton Pump Inhibitors in Patients with Idiopathic Pulmonary Fibrosis

Savarino E, Zentilin P, Marabotto , Savarino V

  • KMID: 2433467
  • J Neurogastroenterol Motil.
  • 2016 Oct;22(4):710-711.
  • doi: 10.5056/jnm16120
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Proton Pump Inhibitors Should be Used with Caution in Critically Ill Patients to Prevent the Risk of Clostridium difficile Infection

Min JH, Kim YS

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Does Long-Term Proton Pump Inhibitor Therapy Affect the Health of Gut Microbiota?

Lee C, Hong SN

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Improvement of Los Angeles Grade D Esophagitis with Proton Pump Inhibitor

Jeon JH, Cheung DY

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effects on Nutrition, Metabolism and Infection by Proton Pump Inhibitors: Unsafe Perspective

Cha BK, Choi CH

  • KMID: 2263936
  • Korean J Med.
  • 2011 Jul;81(1):17-25.
Proton pump inhibitors (PPI) are very effective drug used frequently in acid-related disorders. Long-term use of PPI is becoming increasingly common, often without appropriate indications. The debate had focused on...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Role of Acid Suppression in Acid-related Diseases: Proton Pump Inhibitor and Potassium-competitive Acid Blocker

Mori H, Suzuki H

  • KMID: 2433493
  • J Neurogastroenterol Motil.
  • 2019 Jan;25(1):6-14.
  • doi: 10.5056/jnm18139
Proton pump inhibitors are commonly utilized for the treatment of gastric acid-related diseases, such as gastroesophageal reflux disease, peptic ulcer disease, and Helicobacter pylori infection, and for the prevention of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Proton Pump Inhibitor for Gastroesophageal Reflux Disease: Intelligent Prescription

Jo YJ

  • KMID: 2267876
  • Korean J Med.
  • 2013 Feb;84(2):186-195.
Gastroesophageal reflux disease (GERD) has a chronicity and its symptoms wax and wane by proton pump inhibitor (PPI) therapy. Chronic consumption of PPI in the patients with GERD is common,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Unmet Needs in the Treatment of Gastroesophageal Reflux Disease

Dickman R, Maradey-Romero C, Gingold-Belfer R, Fass R

  • KMID: 2433470
  • J Neurogastroenterol Motil.
  • 2015 Jul;21(3):309-319.
  • doi: 10.5056/jnm15105
Gastroesophageal reflux disease (GERD) is a highly prevalent gastrointestinal disorder. Proton pump inhibitors have profoundly revolutionized the treatment of GERD. However, several areas of unmet need persist despite marked improvements...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pharmacological Therapy of Peptic Ulcer

Oh JH

Peptic ulcer disease is one of the most commonly encountered diseases. Despite the decrease of Helicobacter pylori infection, the use of aspirin and non-steroidal anti-inflammatory drugs has increased in recent...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr